Citius Oncology Inc
Biotechnology
Citius Oncology Inc (CTOR) Stock News
The latest CTOR headlines and market coverage — 3 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
Inspire Medical Systems presented new clinical data at SLEEP 2026 demonstrating the effectiveness of its Inspire V hypoglossal nerve stimulation system for obstructive sleep apnea treatment. Key findings include significant reductions in hypoxic burden, improved cardiovascular outcomes compared to CPAP therapy, and higher patient adherence rates. The company also published studies identifying predictors for therapy eligibility and presented results from its 5,000-patient ADHERE registry showing 62% median AHI reduction.
- Benzinga·
TOURMALINE DECLARES QUARTERLY DIVIDEND AND ANNOUNCES ELECTION OF DIRECTORS
Tourmaline Oil Corp. announced a quarterly cash dividend of $0.50 per share payable on June 30, 2026, and held its annual shareholder meeting on June 3, 2026, where ten directors were elected. The company is Canada's largest natural gas producer focused on low-cost development in the Western Canadian Sedimentary Basin.
- GlobeNewswire Inc.·
UMH PROPERTIES, INC. CONGRATULATES ITS DIRECTORS ON THEIR REELECTION AT THE ANNUAL SHAREHOLDER MEETING
UMH Properties, Inc. announced the reelection of its four directors at the 2026 annual shareholder meeting. The company highlighted strong performance with a 16.4% three-year total shareholder return and 159.5% ten-year return, positioning it among top-performing REITs. UMH also received multiple industry awards including Community Operator of the Year for the fifth time from the Manufactured Housing Institute.